{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T04:32:12Z","timestamp":1768105932093,"version":"3.49.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,12,4]],"date-time":"2019-12-04T00:00:00Z","timestamp":1575417600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["5T32AI100851"],"award-info":[{"award-number":["5T32AI100851"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Mycology Case Reports"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.mmcr.2019.12.007","type":"journal-article","created":{"date-parts":[[2019,12,5]],"date-time":"2019-12-05T12:53:01Z","timestamp":1575550381000},"page":"17-21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["A case of CNS aspergillosis in a patient with chronic lymphocytic leukemia on first-line ibrutinib therapy"],"prefix":"10.1016","volume":"27","author":[{"given":"Emily M.","family":"Eichenberger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Saullo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle","family":"Brander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shih-Hsiu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John R.","family":"Perfect","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia A.","family":"Messina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"25","key":"10.1016\/j.mmcr.2019.12.007_bib1","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1056\/NEJMoa1509388","article-title":"Ibrutinib as initial therapy for patients with chronic lymphocytic leukemia","volume":"373","author":"Burger","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.mmcr.2019.12.007_bib2","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S1470-2045(15)00465-9","article-title":"Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS): a randomised, double-blind, phase 3 study","volume":"17","author":"Chanan-Khan","year":"2016","journal-title":"Lancet Oncol."},{"issue":"12","key":"10.1016\/j.mmcr.2019.12.007_bib3","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1080\/10428194.2017.1320710","article-title":"Fungal infections in patients treated with ibrutinib: two unusual cases of invasive aspergillosis and cryptococcal meningoencephalitis","volume":"58","author":"Baron","year":"2017","journal-title":"Leuk. Lymphoma"},{"issue":"1","key":"10.1016\/j.mmcr.2019.12.007_bib4","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/cid\/cix687","article-title":"Call for action: invasive fungal infections associated with ibrutinib and other small molecule kinase inhibitors targeting immune signaling pathways","volume":"66","author":"Chamilos","year":"2018","journal-title":"Clin. Infect. Dis."},{"issue":"6","key":"10.1016\/j.mmcr.2019.12.007_bib5","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.ccell.2017.04.012","article-title":"Inhibition of B Cell receptor signaling by ibrutinib in primary CNS lymphoma","volume":"31","author":"Lionakis","year":"2017","journal-title":"Cancer Cell"},{"issue":"12","key":"10.1016\/j.mmcr.2019.12.007_bib6","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1111\/myc.13001","article-title":"Ibrutinib associated invasive fungal diseases in patients with CLL and non-Hodgkin lymphoma: an observational study","volume":"62","author":"Ruchlemer","year":"2019","journal-title":"Mycoses"},{"issue":"5","key":"10.1016\/j.mmcr.2019.12.007_bib7","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/cid\/ciy175","article-title":"Serious infections in patients receiving ibrutinib for treatment of lymphoid cancer","volume":"67","author":"Varughese","year":"2018","journal-title":"Clin. Infect. Dis."},{"issue":"3","key":"10.1016\/j.mmcr.2019.12.007_bib8","doi-asserted-by":"crossref","first-page":"240","DOI":"10.15252\/emmm.201404556","article-title":"Phagocytosis-dependent activation of a TLR9-BTK-calcineurin-NFAT pathway co-ordinates innate immunity to Aspergillus fumigatus","volume":"7","author":"Herbst","year":"2015","journal-title":"EMBO Mol. Med."},{"issue":"18","key":"10.1016\/j.mmcr.2019.12.007_bib9","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1182\/blood-2017-12-823393","article-title":"Ibrutinib blocks Btk-dependent NF-kB and NFAT responses in human macrophages during Aspergillus fumigatus phagocytosis","volume":"132","author":"Bercusson","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.mmcr.2019.12.007_bib10","article-title":"Ibrutinib induces multiple functional defects in the neutrophil response against Aspergillus fumigatus","author":"Blez","year":"2019","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.mmcr.2019.12.007_bib11","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/00005792-200007000-00006","article-title":"Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group","volume":"79","author":"Patterson","year":"2000","journal-title":"Medicine (Baltim.)"},{"issue":"5","key":"10.1016\/j.mmcr.2019.12.007_bib12","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jinf.2012.08.003","article-title":"Clinical epidemiology of 960 patients with invasive aspergillosis from the PATH Alliance registry","volume":"65","author":"Steinbach","year":"2012","journal-title":"J. Infect."},{"issue":"17","key":"10.1016\/j.mmcr.2019.12.007_bib13","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1182\/blood-2017-11-818286","article-title":"Early-onset invasive aspergillosis and other fungal infections in patients treated with ibrutinib","volume":"131","author":"Ghez","year":"2018","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.mmcr.2019.12.007_bib14","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s12550-018-0320-7","article-title":"Gliotoxin penetrates and impairs the integrity of the human blood-brain barrier in vitro","volume":"34","author":"Patel","year":"2018","journal-title":"Mycotoxin Res."},{"issue":"6","key":"10.1016\/j.mmcr.2019.12.007_bib15","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/MD.0b013e318274cd77","article-title":"Central nervous system aspergillosis: a series of 14 cases from a general hospital and review of 123 cases from the literature","volume":"91","author":"Kourkoumpetis","year":"2012","journal-title":"Medicine (Baltim.)"},{"issue":"18","key":"10.1016\/j.mmcr.2019.12.007_bib16","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1182\/blood-2018-08-865659","article-title":"Ibrutinib and Aspergillus: a Btk-targeted risk","volume":"132","author":"Woyach","year":"2018","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.mmcr.2019.12.007_bib17","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.medmal.2018.01.003","article-title":"Cerebral aspergillosis: an emerging opportunistic infection in patients receiving ibrutinib for chronic lymphocytic leukemia?","volume":"48","author":"Gaye","year":"2018","journal-title":"Med. Maladies Infect."},{"issue":"16","key":"10.1016\/j.mmcr.2019.12.007_bib18","first-page":"1593","article-title":"Ibrutinib for chronic lymphocytic leukemia","volume":"374","author":"Ruchlemer","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.mmcr.2019.12.007_bib19","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1158\/1078-0432.CCR-16-1948","article-title":"Long-term follow-up of treatment with ibrutinib and rituximab in patients with high-risk chronic lymphocytic leukemia","volume":"23","author":"Jain","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.mmcr.2019.12.007_bib20","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.mmcr.2019.02.005","article-title":"Cranial aspergillosis in a patient receiving ibrutinib for chronic lymphocytic leukemia","volume":"24","author":"Beresford","year":"2019","journal-title":"Med. Mycol. Case Rep."}],"container-title":["Medical Mycology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211753919301204?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211753919301204?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T18:02:09Z","timestamp":1761933729000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211753919301204"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":20,"alternative-id":["S2211753919301204"],"URL":"https:\/\/doi.org\/10.1016\/j.mmcr.2019.12.007","relation":{},"ISSN":["2211-7539"],"issn-type":[{"value":"2211-7539","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A case of CNS aspergillosis in a patient with chronic lymphocytic leukemia on first-line ibrutinib therapy","name":"articletitle","label":"Article Title"},{"value":"Medical Mycology Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mmcr.2019.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier B.V. on behalf of International Society for Human and Animal Mycology.","name":"copyright","label":"Copyright"}]}}